Details of the Drug Formulations

General Information of Drug (ID: DM1FX74)

Drug Name
Bretylium Drug Info
Synonyms
Bretylum; Bretylium tolsylate; Bretylium tosylate(USAN); N-(2-bromobenzyl)-N,N-dimethylethanaminium; N-ethyl-N,N-dimethyl-2-bromobenzenemethanaminium; Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1); (2-bromobenzyl)ethyldimethylaminium; (2-bromophenyl)methyl-ethyl-dimethylazanium; (o-Bromobenzyl)ethyldimethylammonium p-toluenesulfonate; 2-bromo-N-ethyl-N,N-dimethylbenzenemethanaminium
Indication
Disease Entry ICD 11 Status REF
Long QT syndrome BC65.0 Approved [1]
Ventricular fibrillation BC71.1 Approved [2]
Therapeutic Class
Antiarrhythmic Agents
Cross-matching ID
PubChem CID
2431
ChEBI ID
CHEBI:3172
CAS Number
59-41-6
TTD ID
D02YYF
VARIDT ID
DR01325
ACDINA ID
D00890

Full List of Drug Formulations Containing This Drug

Bretylium 50mg/ml injectable
Company Formulation ID FDA Description
Ani Pharmaceuticals F23091 Sodium Hydroxide; Hydrochloric Acid
------------------------------------------------------------------------------------

References

1 Bretylium FDA Label
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015